Grants
ERC PoC
PoC Validation
DTS
Biomarker Validation
CaixaImpulse Validate
New Chemical Entity Development
CRAASH Barcelona
Program that helps European research teams launch successful diagnostic innovations to improve health and patient care
FIPSE
Ayudas para financiar estudios de viabilidad de las innovaciones en Salud
AECC INNOVA
Lead Optimization
DTS
PoC in CRC
Torres Quevedo
Ayuda PTQ2021-012018 financiada por MCIN/AEI
AGAUR Doctorat Industrial
NEOTEC
SNEO-20231204
MISIONES PERTE
MIG-20231023 – IMPACT Photonics – Investigación para la Integración de Nuevas Arquitecturas Sensoras de Fotónica Integrada Multiplexada y Terahercios Hiperespectrales para un Sistema Microfluídico In Vitro para Monitorizar Tratamientos Farmacológicos contra el Cáncer
Our investors
AtG Therapeutics is a preclinical stage drug development biotech that specialises in the discovery of metabolic adaptation targets and therapies to treat advanced cancer
AtG is currently looking for investors in order to fund the preclinical development of AtG-153.
Would it be you?